Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Asbestos: Use, Bans And Disease Burden In Europe

T. Kameda, K. Takahashi, R. Kim, Y. Jiang, M. Movahed, E. Park, J. Rantanen
Published 2014 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Abstract Objective To analyse national data on asbestos use and related diseases in the European Region of the World Health Organization (WHO). Methods For each of the 53 countries, per capita asbestos use (kg/capita/year) and age-adjusted mortality rates (deaths/million persons/year) due to mesothelioma and asbestosis were calculated using the databases of the United States Geological Survey and WHO, respectively. Countries were further categorized by ban status: early-ban (ban adopted by 2000, n = 17), late-ban (ban adopted 2001–2013, n = 17), and no-ban (n = 19). Findings Between 1920–2012, the highest per capita asbestos use was found in the no-ban group. After 2000, early-ban and late-ban groups reduced their asbestos use levels to less than or equal to 0.1 kg/capita/year, respectively, while the no-ban group maintained a very high use at 2.2 kg/capita/year. Between 1994 and 2010, the European Region registered 106 180 deaths from mesothelioma and asbestosis, accounting for 60% of such deaths worldwide. In the early-ban and late-ban groups, 16/17 and 15/17 countries, respectively, reported mesothelioma data to WHO, while only 6/19 countries in the no-ban group reported such data. The age-adjusted mortality rates for mesothelioma for the early-ban, late-ban and no-ban groups were 9.4, 3.7 and 3.2 deaths/million persons/year, respectively. Asbestosis rates for the groups were 0.8, 0.9 and 1.5 deaths/million persons/year, respectively. Conclusion Within the European Region, the early-ban countries reported most of the current asbestos-related deaths. However, this might shift to the no-ban countries, since the disease burden will likely increase in these countries due the heavy use of asbestos.
This paper references
Population statistics: historical demography of all countries, their divisions and towns [Internet
J. Lahmeyer (2006)
Copenhagen: World Health Organization Regional Office for Europe Available from: http://www. euro.who.int/en/who-we-are/policy-documents/parma-declaration-onenvironment-and-health
(2010)
The World Health Report 2000: Health Systems: Improving Performance
K. Hill (2001)
Available from: www3.ha.org.hk/cancereg/statistics.html
Hong Kong (2013)
10.1146/annurev-publhealth-031811-124704
The worldwide pandemic of asbestos-related diseases.
L. Stayner (2013)
Population statistics: historical demography of all countries, their divisions and towns
J Lahmeyer (2006)
10.1111/j.1440-1843.2011.01975.x
Asbestos use and asbestos‐related diseases in Asia: Past, present and future
G. Le (2011)
Mineral industry surveys. World asbestos consumption from
(2003)
Health statistics and health information systems. WHO mortality database [Internet]. Geneva: World Health Organization
(2013)
The Helsinki Declaration on Management and Elimination of Asbestos-Related Diseases. Rome: International Commission on Occupational Health
10.1016/S0033-3549(04)50043-2
The World Health Report 2000: Health Systems: Improving Performance. Geneva: World Health Organization; 2000. 150 pages plus tables; $13.50; available on-line from: URL: http://www.who.int/whr/
A. Robbins (2001)
cancer registry [Internet]. Hong Kong: Hospital Authority
Hong Kong (2014)
Cancer mortality pattern in Viet Nam.
L. Ngoan (2007)
10.1016/S0140-6736(07)60412-7
Ecological association between asbestos-related diseases and historical asbestos consumption: an international analysis
Ro-Ting Lin (2007)
Copenhagen: World Health Organization Regional Office for Europe
(2010)
10.1016/j.lungcan.2009.05.016
Impact of malignant mesothelioma in Taiwan: a 27-year review of population-based cancer registry data.
L. Lee (2010)
Thirteen session of the Joint ILO/WHO Committee on occupational health
10.2218/RESMEDICA.V21I1.510
World Health Report
Thomas Prentice (2013)
Malignant tumors caused by asbestos: recognition as occupational diseases
M Rüegger (2007)
10.1289/ehp.11272
Recent Mortality from Pleural Mesothelioma, Historical Patterns of Asbestos Use, and Adoption of Bans: A Global Assessment
K. Nishikawa (2008)
Worldwide asbestos supply and consumption trends from 1900 through 2003. Circular 1298. Reston: United States Geological Survey
R L Virta (2006)
10.1289/ehp.0900868
Are Current or Future Mesothelioma Epidemics in Hong Kong the Tragic Legacy of Uncontrolled Use of Asbestos in the Past?
L. A. Tse (2010)
Outline for the development of national programmes for the elimination of asbestos-related diseases. Geneva: International Labour Organization/ World Health Organization
(2007)
The Human and Financial Burden of Asbestos in the WHO European Region
(2006)
Copenhagen: World Health Organization Regional Office for Europe
Germany Bonn (2013)
Cancer mortality pattern in Viet Nam.
T. Ngoanle (2007)
The International statistical classification of diseases and health related problems ICD-10
(1992)
10.1002/(SICI)1097-0274(199804)33:4<321::AID-AJIM2>3.0.CO;2-X
South African asbestos: production, exports, and destinations, 1959-1993.
J. Harington (1998)
10.1289/ehp.1002845
Global Magnitude of Reported and Unreported Mesothelioma
Eun-Kee Park (2011)
10.1179/oeh.2004.10.1.22
Global Use of Asbestos and the Incidence of Mesothelioma
A. Tossavainen (2004)
AGE STANDARDIZATION OF RATES: A NEW WHO STANDARD
O. B. Ahmad (2000)
Washington: United States Census Bureau Available from: http://www.census.gov/population/ international/data/idb/informationGateway
(2012)
10.1136/oem.2008.039172
Asbestosis mortality in the USA: facts and predictions
V. C. dos Santos Antao (2008)
Washington: United States Census Bureau
(2012)
Hospital Authority
Hong Kong Cancer Registry [ Internet (2013)
Malignant tumors caused by asbestos: recognition as occupational diseases In: Medical Information No. 78. Lucerne: Swiss accident insurance institution (SUVA) Available from: https://wwwepp1
M Rüegger (2007)
Contribution of occupational risk factors to the global burden of disease— a summary of findings 1
M. Fingerhut (2005)
Asbestos: elimination of asbestos-related diseases. Fact sheet N°343. Geneva: World Health Organization
(2010)
10.3133/CIR1298
Worldwide asbestos supply and consumption trends from 1900 to 2000
R. L. Virta (2003)
London: International Ban Asbestos Secretariat
(2013)
10.1038/159114a0
The United Nations
R. B. (1947)
Population statistics: historical demography of all countries, their divisions and towns [Internet]. Utrecht: Populstat; 2006. Available from: http://www
J Lahmeyer (2013)
10.1289/EHP.6704
The asbestos cancer epidemic.
J. LaDou (2004)
Health statistics and health information systems. WHO mortality database
(2012)
Chronology of national asbestos bans [Internet]. London: International Ban Asbestos Secretariat; 2013. Available from
Geneva: International Labour Organization Available from: http://www.ilo.org/dyn/ normlex
(1986)
10.1136/jcp.48.7.691-a
IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
A. Zuckerman (2010)
Geneva: International Labour Organization
(1986)
Elimination of asbestos-related diseases. Geneva: World Health Organization
(2006)
Hong Kong cancer registry
10.32388/pfg7jq
International agency for research on cancer.
J. Higginson (1974)
10.1002/AJIM.20210
The global burden of non-malignant respiratory disease due to occupational airborne exposures.
T. Driscoll (2005)
10.1002/AJIM.20209
The global burden of disease due to occupational carcinogens.
T. Driscoll (2005)



This paper is referenced by
10.1155/2015/264568
An Unjustified Prognosis of the Number of Asbestos-Related Lung Cancer Cases Caused by an Increase in Airborne Asbestos Concentrations as a Result of Removing of Asbestos-Cement Products
N. Szeszenia-Dąbrowska (2015)
Emerging evidence that the ban on asbestos use is reducing the occurrence of pleural mesothelioma in Sweden
E. Mc (2015)
10.1007/s40572-016-0109-9
Recent Scientific Evidence Regarding Asbestos Use and Health Consequences of Asbestos Exposure
M. Valenzuela (2016)
10.1177/1403494815596500
Emerging evidence that the ban on asbestos use is reducing the occurrence of pleural mesothelioma in Sweden
B. Järvholm (2015)
10.5603/ARM.a2020.0103
New horizons from novel therapies in malignant pleural mesothelioma.
M. Sayan (2020)
10.4155/bio.15.53
Bioanalytical techniques for detecting biomarkers of response to human asbestos exposure.
Clementina A. Mesaros (2015)
10.1183/13993003.00961-2017
Chest physician-reported, work-related, long-latency respiratory disease in Great Britain
M. Carder (2017)
10.1093/ije/dyy212
Impact of low-dose computed tomography screening on lung cancer mortality among asbestos-exposed workers.
F. Barbone (2018)
10.3390/ijerph15081638
Relationships of Lower Lung Fibrosis, Pleural Disease, and Lung Mass with Occupational, Household, Neighborhood, and Slate Roof-Dense Area Residential Asbestos Exposure
D. Kang (2018)
10.1007/978-3-030-19412-3_3
Identification of Health Risk Factors and Their Parameters
Mateja Dovjak (2019)
10.1002/ijc.30897
Asbestos‐associated genome‐wide DNA methylation changes in lung cancer
E. Kettunen (2017)
10.1080/13662716.2020.1830041
Asbestos, leaded petrol, and other aberrations: Comparing countries’ regulatory responses to disapproved products and technologies
Alexander Coad (2020)
10.1016/j.lungcan.2017.03.012
Mesothelioma continues to increase even 40 years after exposure - Evidence from long-term epidemiological observation.
B. Świątkowska (2017)
10.1016/S2213-2600(16)30424-6
Occupational lung diseases: from old and novel exposures to effective preventive strategies.
P. Cullinan (2017)
DIRECTORATE GENERAL FOR INTERNAL POLICIES POLICY DEPARTMENT A: ECONOMIC AND SCIENTIFIC POLICY
Emu Reforms (2012)
10.6002/ect.2016.0292
Effect of Single Sensitization Event on Human Leukocyte Antigen Alloimmunization in Kidney Transplant Candidates: A Single-Center Experience.
M. Resse (2018)
10.26444/aaem/118898
Asbestosis hospitalizations in Poland (2006-2016): results from the National Hospital Discharge Registry.
K. Kanecki (2020)
10.21037/tlcr.2018.04.09
Breath analysis as a diagnostic and screening tool for malignant pleural mesothelioma: a systematic review.
Lisa Brusselmans (2018)
10.3389/fonc.2020.00343
Emerging Treatments for Malignant Pleural Mesothelioma: Where Are We Heading?
L. Cantini (2020)
Distinction between mesothelioma and lung adenocarcinoma based on immunohistochemistry in a patient with asbestos bodies in bronchoalveolar fluid - case report.
A. Rașcu (2016)
10.13075/ijomeh.1896.01148
Histological findings and lung dust analysis as the basis for occupational disease compensation in asbestos-related lung cancer in Germany.
I. Feder (2018)
10.2471/BLT.15.159426
Medical monitoring of asbestos-exposed workers: experience from Poland
B. Świątkowska (2016)
10.1155/2017/1797512
Glycoprotein YKL-40 Levels in Plasma Are Associated with Fibrotic Changes on HRCT in Asbestos-Exposed Subjects
Tuija Väänänen (2017)
10.3390/ijerph17186900
Burden of Mesothelioma Deaths by National Income Category: Current Status and Future Implications
Odgerel Chimed-Ochir (2020)
10.2139/ssrn.2681092
Eliminating Occupational Cancer in Europe and Globally
J. Takala (2015)
10.1016/j.wasman.2016.02.014
Classification and management of asbestos-containing waste: European legislation and the Italian experience.
F. Paglietti (2016)
10.1080/10937404.2016.1193361
Five years update on relationships between malignant pleural mesothelioma and exposure to asbestos and other elongated mineral particles
P. Andujar (2016)
10.1007/s40735-019-0253-5
Tribological Behavior of Multi-walled Carbon Nanotubes Grafted Carbon Fiber-reinforced Friction Material
N. K. Konada (2019)
10.1016/S1470-2045(18)30100-1
Novel therapies for malignant pleural mesothelioma.
A. Scherpereel (2018)
10.1245/s10434-019-07803-z
Malignant Peritoneal Mesothelioma: Patterns of Care and Survival in the Netherlands: A Population-Based Study
Nadine L de Boer (2019)
10.1155/2017/9280170
Circulating miR-132-3p as a Candidate Diagnostic Biomarker for Malignant Mesothelioma
D. Weber (2017)
10.3390/ijerph15010143
Asbestos-Related Disorders in Germany: Background, Politics, Incidence, Diagnostics and Compensation
X. Baur (2018)
See more
Semantic Scholar Logo Some data provided by SemanticScholar